89 related articles for article (PubMed ID: 9301702)
1. Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate.
Werner-Wasik M; Whittington R; Malkowicz SB; Corn BW; Arger P; Reisinger S; Langlotz C; Alexander A; D'Amico AV; Hyslop T; Gomella L; Brownstein K; Wein AJ
Urology; 1997 Sep; 50(3):385-9. PubMed ID: 9301702
[TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
[TBL] [Abstract][Full Text] [Related]
3. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
[TBL] [Abstract][Full Text] [Related]
4. Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
Weiss BE; Wein AJ; Malkowicz SB; Guzzo TJ
Urol Oncol; 2013 Nov; 31(8):1436-40. PubMed ID: 22503576
[TBL] [Abstract][Full Text] [Related]
5. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer.
May F; Treumann T; Dettmar P; Hartung R; Breul J
BJU Int; 2001 Jan; 87(1):66-9. PubMed ID: 11121995
[TBL] [Abstract][Full Text] [Related]
6. The value of endorectal MRI in the early diagnosis of prostate cancer.
Comet-Batlle J; Vilanova-Busquets JC; Saladié-Roig JM; Gelabert-Mas A; Barceló-Vidal C
Eur Urol; 2003 Aug; 44(2):201-7; discussion 207-8. PubMed ID: 12875939
[TBL] [Abstract][Full Text] [Related]
7. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
Lattouf JB; Grubb RL; Lee SJ; Bjurlin MA; Albert P; Singh AK; Ocak I; Choyke P; Coleman JA
BJU Int; 2007 May; 99(5):1041-6. PubMed ID: 17437438
[TBL] [Abstract][Full Text] [Related]
10. [Significance of endorectal nuclear magnetic resonance tomography and transrectal ultrasound diagnosis in local staging of prostatic carcinoma].
May F; Treumann T; Dettmar P; Hartung R; Breul J
Urologe A; 2002 Sep; 41(5):458-61. PubMed ID: 12426863
[TBL] [Abstract][Full Text] [Related]
11. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions.
Cornud F; Belin X; Piron D; Chrétien Y; Flam T; Casanova JM; Hélénon O; Méjean A; Thiounn N; Moreau JF
Urology; 1997 May; 49(5):709-15. PubMed ID: 9145975
[TBL] [Abstract][Full Text] [Related]
12. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
13. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
Epstein JI; Walsh PC; Carmichael M; Brendler CB
JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
Augustin H; Graefen M; Palisaar J; Blonski J; Erbersdobler A; Daghofer F; Huland H; Hammerer PG
J Clin Oncol; 2003 Aug; 21(15):2860-8. PubMed ID: 12885802
[TBL] [Abstract][Full Text] [Related]
15. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].
de Vendin C; Eydant Y; Ecochard R; Lorin S; Lacroix B; Lardon R; Mottet N
Prog Urol; 2013 Dec; 23(16):1412-8. PubMed ID: 24274946
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors.
Ferguson JK; Bostwick DG; Suman V; Zincke H; Oesterling JE
Eur Urol; 1995; 27(1):8-12. PubMed ID: 7538082
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242
[TBL] [Abstract][Full Text] [Related]
19. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
